Sign in
Taking people in United StatesNo phase

Surgeon-modified stent grafts for aortic aneurysms near the kidneys and chest

Tests surgeon-modified endografts in adults with pararenal or thoracoabdominal aortic aneurysm unsuitable for open surgery.

Key facts

Who runs it
Konstantinos Arnaoutakis, MD
Where
Wesley Chapel, United StatesSee the site
Trial code
Registry title
PMEG for Repair of Pararenal and Thoracoabdominal Aortic Aneurysm
Status
Recruiting
People taking part
300 people, planned
Started
6 Jun 2023
Expected to end
Feb 2030
Type of study
Interventional
Treatments tested
  • PMEG
Record updated
16 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a pararenal or thoracoabdominal aortic aneurysm (a bulge in the main artery near the kidneys or chest and belly). They cannot have open surgery because of other health problems. Their anatomy does not allow standard ready-made stent grafts.

Age
18 years or older
Sex
Male or female
Disease stage
Aneurysm of the thoracoabdominal or pararenal aorta, with or without chronic dissection. A standard graft would need to cover the celiac, SMA and/or renal arteries. Expected survival beyond 1 year after repair.

Main reasons for not taking part

  • Can be treated with a marketed stent graft, including a factory-made custom device, or can join a manufacturer study
  • Ruptured aneurysm with unstable blood pressure or circulation
  • Severe heart failure, unstable angina, or stroke or heart attack within 3 months
  • eGFR below 30ml/min, unless on or starting dialysis
  • Pregnancy or breastfeeding, or active body-wide infection

The registry criteria, word for word

Show all 29 criteriaShow less

Who can take part

  • Provision of signed and dated informed consent form
  • Male or female, aged ≥18 years
  • Expected survival beyond 1 year following successful aneurysm repair
  • Anatomy that would require coverage of the celiac artery, superior mesenteric artery (SMA), and/or renal arteries if conventional, FDA-approved endograft were implanted to obtain adequate sealing zone length
  • Aneurysm of the thoracoabdominal or pararenal aorta with or without chronic dissection
  • Adequate proximal zone of fixation
  • Adequate distal zone of fixation
  • No more than 5 non-aneurysmal visceral (celiac, SMA, or renal) arteries with diameters between 4-12mm
  • Adequate arterial access for delivery system; use of iliac conduit is permitted as necessary

Who cannot take part

  • Pregnancy or lactation (confirmed per standard of care surgical practice)
  • Major, unrelated surgical procedure planned ≤30 days from endovascular repair
  • Patient is ≤30 days beyond primary endpoint for another investigative clinical drug/device trial
  • Unstable angina
  • Stroke or MI within 3 months of planned treatment date
  • Active systemic infection and/or mycotic aneurysm
  • Uncorrectable coagulopathy or other bleeding diathesis
  • Known allergy to device material or contrast material that cannot be adequately pre-medicated
  • Baseline eGFR < 30ml/min, unless currently on or to be initiating dialysis
  • Moderate-to-severe aortic neck calcification, thrombus, or tortuosity
  • Severe iliac stenosis, calcification, or tortuosity with no ability to perform a conduit
  • Proximal landing within zone 0 or 1
  • Inability to maintain at least one patent hypogastric artery
  • Freely ruptured aneurysm with hemodynamic instability
  • Non-ambulatory status
  • Severe CHF
  • Body habitus that would preclude adequate fluoroscopic visualization of aorta
  • Social or psychological issues that would interfere with ability to comply with all study procedures for the duration of the study
  • Can be treated in accordance with the instructions for use with a legally marketed endovascular device, including a manufacturer-fabricated custom device
  • Can enroll in a manufacturer-sponsored clinical study at our institution or is willing and eligible to participate in a study with a manufacturer-made device at another institution

Where in United States

  • Orlando Health Wiregrass Ranch HospitalWesley Chapel, United StatesContact: TIna HendersonTaking people

About the trial

What the trial wants to find out

The primary objective is to evaluate the safety and effectiveness of surgeon modified endografts for the treatment of pararenal and thoracoabdominal aortic pathology in patients who are not candidate for traditional open repair due to comorbid issues and their anatomy is not amenable to commercially available endografts.

The group in the trial

  • Physician-modified endograftsTreatment being tested

    For this clinical protocol, endografts which are commercially available will be modified in a sterile fashion on a back-table in the operating room.

    Treatment: PMEG

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluation of Spinal Cord Ischemia and Mortality and Morbidity After Endovascular Repair of Pararenal and Thoracoabdominal Aortic Aneurysm Using Surgeon-Modified Endografts
Plain-language title
Surgeon-modified stent grafts for aortic aneurysms near the kidneys and chestGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Publications
Record updated
16 October 2026